gastroesophageal reflux disease

Search with Google Search with Bing
Information
Disease name
gastroesophageal reflux disease
Disease ID
DOID:8534
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04711655 Active, not recruiting N/A Antireflux Ablation of the Cardia Mucosa vs Placebo for the Treatment of Gastroesophageal Reflux Disease March 1, 2021 June 2024
NCT05614752 Active, not recruiting Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab July 6, 2022 December 31, 2024
NCT02923362 Active, not recruiting Registry of Outcomes From AntiReflux Surgery May 2016 May 2025
NCT05886933 Active, not recruiting Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet May 22, 2023 December 31, 2024
NCT05365087 Active, not recruiting Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients March 1, 2018 December 31, 2032
NCT01921686 Active, not recruiting Morphological Markers of Gastroesophageal Reflux Disease (GERD) March 2013 February 2025
NCT04408105 Active, not recruiting Survey Study on Barrett's Esophagus Screening February 19, 2020 September 2024
NCT00260572 Active, not recruiting Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease April 1999 December 2050
NCT00206180 Completed Phase 4 NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis June 2004 August 2005
NCT00214552 Completed Phase 3 Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. September 2002 March 2005
NCT00217347 Completed N/A Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy September 2005 July 2006
NCT00220818 Completed Phase 1 A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease. January 2005 July 2005
NCT00251732 Completed Phase 4 Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) March 2005 May 2010
NCT00251745 Completed Phase 3 Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn December 2005 May 2006
NCT00251758 Completed Phase 3 Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn December 2005 May 2006
NCT00255190 Completed Phase 3 Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn January 2006 June 2008
NCT00272701 Completed Phase 4 Esomeprazole in PPI Failures - IMPROVE December 2005 February 2007
NCT00287612 Completed N/A Necessity of Esophageal Dissection During Laparoscopic Fundoplication February 2006 August 2009
NCT00304421 Completed Phase 4 Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD January 2004 September 2007
NCT00321984 Completed Phase 3 Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease June 2006 December 2006
NCT00324974 Completed Phase 3 The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux June 2006 May 2007
NCT00325676 Completed Phase 4 Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342) June 2006
NCT00343161 Completed Phase 4 Symptom Adapted Therapy in GERD Patients August 2006 August 2007
NCT00373334 Completed Phase 3 Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) August 2006 February 2008
NCT00378898 Completed N/A Feasibility of Placing Bravo PH Capsule in Proximal Esophagus September 2006 July 2009
NCT00405119 Completed Phase 2 A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. May 2006 March 2007
NCT00410592 Completed Phase 4 Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD October 2006 May 2007
NCT00414856 Completed Phase 1 Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux August 2006
NCT05647668 Completed N/A Laparoscopic Total vs Partial Fundoplication in Patients With Atypical Symptoms of Gastroesophageal Reflux Disease March 1, 2018 April 6, 2021
NCT00476398 Completed Phase 4 Evaluation of Patients With Non-cardiac Chest Pain January 2006 June 2009
NCT00492622 Completed Phase 4 Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis June 2007 December 2008
NCT05405816 Completed N/A Determination of Change in Reflux Disease After Sleeve Gastrectomy by Intraluminal Impedance and pH-meter January 1, 2022 September 1, 2022
NCT00507377 Completed Foreshortened Esophagus and Its Surgical Therapy September 2005 July 2007
NCT00521703 Completed Phase 3 Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children August 2007 April 2008
NCT00539240 Completed Phase 2/Phase 3 Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI April 2006 November 2011
NCT05193266 Completed Gastroesophageal Reflux Disease (GERD) Among ICU Survivors January 14, 2022 August 5, 2023
NCT00551473 Completed Phase 1 Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg. May 2007
NCT00561730 Completed Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD) October 2007 December 2008
NCT05062876 Completed Phase 1 A Study to Compare PK, PD and Safety of the AD-214 and AD-2141 November 1, 2021 March 29, 2022
NCT04703868 Completed Phase 1 A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects January 13, 2021 June 14, 2021
NCT04622358 Completed Phase 1 A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole December 5, 2020 March 8, 2021
NCT00618150 Completed N/A Patient Education in Gastroesophageal Reflux Disease September 1996
NCT00625495 Completed Phase 4 Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) September 2002 November 2002
NCT00626262 Completed Phase 4 Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv July 2002 October 2002
NCT00637845 Completed Phase 4 Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD) June 2002 February 2003
NCT00660660 Completed Phase 4 Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US April 2008 July 2008
NCT00674245 Completed Phase 2/Phase 3 Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD. April 2008 July 2010
NCT00684190 Completed Phase 1 Drug Interaction Study Between AZD3355 and Nexium March 2008 June 2008
NCT00688402 Completed Phase 1 Study to Compare Different Formulations of AZD3355 April 2008 June 2008
NCT00698178 Completed Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease June 2008 August 2009
NCT00728481 Completed Phase 2/Phase 3 The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis May 2008 December 2010
NCT00729339 Completed Phase 4 Role of Mosapride in Patients With Gastroesophageal Reflux Disease June 2008 May 2009
NCT00730106 Completed Endoscopic Findings in Patients With Typical Gastroesophageal Reflux Disease (GERD) Symptoms May 2008 December 2009
NCT04595500 Completed Relationship Between Gastroesophageal Reflux Disease and Dental Erosion January 2009 March 2011
NCT00734097 Completed Phase 4 A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) November 2007 October 2008
NCT00768196 Completed Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients September 2008 February 2009
NCT00768443 Completed Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) September 2008 February 2009
NCT00786695 Completed N/A Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP May 2006 December 2009
NCT00786773 Completed Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment. October 2008 June 2009
NCT00829738 Completed Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease January 2009 June 2009
NCT00830115 Completed Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders January 2009 June 2009
NCT00842855 Completed Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France February 2009 November 2010
NCT00858858 Completed N/A Clinical Studies on Bile Acids in Barrett's Esophagus March 2009 February 2015
NCT00872755 Completed Phase 4 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) January 2002 December 2008
NCT00885469 Completed PillCam® ESO 2 in Esophageal Pathologies December 2007 April 2009
NCT00886197 Completed Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease September 2007 April 2009
NCT00901004 Completed The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire April 2009 September 2009
NCT00914342 Completed Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ July 2009 December 2009
NCT04568772 Completed Phase 1 Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers November 25, 2020 August 3, 2021
NCT00926276 Completed Phase 4 The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia June 2009 May 2013
NCT04494243 Completed Phase 1 A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole August 28, 2020 January 15, 2021
NCT00951093 Completed Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass March 2007 December 2012
NCT00963144 Completed Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study July 2009 November 2009
NCT00978016 Completed Phase 2 A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) September 2009 December 2010
NCT00998244 Completed N/A Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease September 2009 December 2011
NCT01005251 Completed Phase 2 Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI October 2009 July 2010
NCT01020890 Completed Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms November 2009 April 2010
NCT01026103 Completed N/A Tri Staple Technology Stapler Used in Gastric Bypass January 2010 March 2011
NCT01027975 Completed N/A Comparison of Laparoscopic Nissen Versus Thal Fundoplication in Children July 1998
NCT01039558 Completed N/A The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease December 2009 March 2011
NCT01041105 Completed Gastric Bypass After Previous Anti-reflux Surgery December 2008 December 2009
NCT01043185 Completed Phase 2 A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience December 2009 May 2010
NCT01053585 Completed N/A Structure and Function of the Gastro-esophageal Junction February 2007 May 2011
NCT01058070 Completed N/A An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter February 2007 August 2013
NCT01065649 Completed Phase 3 Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients January 2010 June 2010
NCT00057174 Completed N/A Economic Impact of Guidelines for Gastroesophageal Reflux Disease June 2004
NCT04152798 Completed N/A Approach to Hiatal Hernia Repair Based on Collagen Study January 1, 2014 September 20, 2019
NCT01095133 Completed Phase 1 Do Acid Sensing Ion Channels Contribute to Heartburn? March 2010 September 2011
NCT01099735 Completed Effect of Continuous Positive Airway Pressure (CPAP) on Lower Esophageal Sphincter Pressure in Morbidly Obese Patients January 2010 June 2012
NCT03904472 Completed N/A Cognitive Behavioral Therapy for Insomnia (CBTI) in GERD Patients With Insomnia April 15, 2019 March 25, 2022
NCT01110811 Completed N/A Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD) April 2010 December 2018
NCT01118585 Completed N/A Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) May 2010 December 2018
NCT01126034 Completed N/A Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention March 2007 April 2008
NCT03871426 Completed Manual Therapy Effects on Upper and Lower Esophageal Sphincter Pressures March 18, 2019 June 13, 2019
NCT03848494 Completed True Short Esophagus in Gastroesophageal Reflux Disease January 1, 2004 December 31, 2018
NCT01136980 Completed N/A Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study April 2011 March 2018
NCT01149395 Completed Phase 1 Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn June 2010 April 2012
NCT01161602 Completed Phase 2 A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) May 2011
NCT03692455 Completed N/A Clinico-functional Evaluation of GERD: Comparative Study of Vertical Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass October 19, 2016 August 13, 2018
NCT01200550 Completed The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients September 2010 November 2011
NCT01204931 Completed Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)? November 2010 June 2015
NCT01212614 Completed N/A Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients October 2010 September 2012
NCT03616119 Completed Gastroesophageal Reflux Disease in Azerbaijan January 1, 2018 September 1, 2019
NCT01215305 Completed A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece October 2010 March 2011
NCT03516188 Completed Phase 2/Phase 3 Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants July 2016 June 2017
NCT01260935 Completed N/A Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures November 2002 November 2010
NCT01262755 Completed Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology April 2010 January 2015
NCT01321294 Completed N/A Laparoscopic Nissen Versus Toupet Fundoplication: Objective and Subjective Results of a Prospective Randomized Trial
NCT01324791 Completed N/A Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD)
NCT01338077 Completed Phase 3 Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease October 2010 January 2012
NCT03299985 Completed N/A Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease October 5, 2017 March 15, 2018
NCT01381991 Completed N/A The Efficacy of i-Scan for Detecting Reflux Esophagitis July 2010 June 2011
NCT01390714 Completed Phase 1 Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects July 2011 October 2011
NCT03284177 Completed Phase 2 A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients October 31, 2017 December 4, 2018
NCT01397084 Completed Phase 4 To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole August 2011 January 2012
NCT01400945 Completed Phase 3 Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease December 2009 September 2011
NCT03128736 Completed Phase 4 Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B April 1, 2014 March 30, 2016
NCT01432392 Completed Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease September 2011 April 2012
NCT03069963 Completed Phase 1 PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects February 24, 2017 April 23, 2017
NCT03065816 Completed Phase 1 Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects February 9, 2017 May 2, 2017
NCT01472939 Completed Phase 2 Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) February 27, 2012 May 14, 2013
NCT03053609 Completed Gastroesophageal Reflux and Cardiorespiratory Problems January 2006 December 2016
NCT01489735 Completed The Use of International GerdQ Questionnaire February 2012 June 2012
NCT03037606 Completed Phase 4 Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets August 1, 2017 December 11, 2018
NCT01536457 Completed Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only July 2011 January 2013
NCT02958046 Completed Phase 4 The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity January 2014 August 2015
NCT02930824 Completed N/A Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing December 2016 July 17, 2019
NCT01576289 Completed Analysis of Biopsies From the Upper Gastrointestinal Tract November 2011 May 2012
NCT01578642 Completed Phase 2 Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease September 2010 May 2013
NCT01601379 Completed Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. June 2010 June 2011
NCT02893709 Completed N/A Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES) June 2015 July 2016
NCT02890979 Completed N/A Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease August 3, 2016 October 10, 2017
NCT01642602 Completed Phase 2 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents July 2012 January 2014
NCT01642615 Completed Phase 2 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents July 2012 November 2014
NCT01682265 Completed N/A Stretta In Reflux Uncontrolled by IPP March 26, 2012 November 27, 2018
NCT02873689 Completed Phase 3 Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients December 27, 2016 April 19, 2018
NCT02860624 Completed Phase 3 Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients December 2011
NCT01733810 Completed N/A The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis February 1, 2013 July 31, 2019
NCT01742377 Completed Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients February 2010 July 2014
NCT01753128 Completed Phase 3 Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn December 2012 September 2013
NCT01776827 Completed Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital May 22, 2012 February 11, 2015
NCT01777867 Completed Cough Reflex Sensitivity and Bronchial Hyper-responsiveness December 2012 February 2016
NCT02706938 Completed N/A Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease April 8, 2016 November 15, 2017
NCT01798212 Completed N/A Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD. August 2013 December 2016
NCT01806220 Completed N/A Laryngeal and Esophageal EGF-r Expression in Patients With Reflux Laryngitis January 2004 December 2007
NCT01818570 Completed Phase 1 A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus January 2013 January 2014
NCT02685436 Completed Phase 4 Role of Pepsin Assay in Wheezy Infants March 2013 May 2015
NCT01844440 Completed N/A Diagnostic of Transient Lower Esophageal Sphincter Relaxation With Combined Impedance and High Resolution Manometry in Patients With GERD April 2013 January 2014
NCT01869491 Completed Phase 3 Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study June 2013 May 2014
NCT01872897 Completed Phase 3 Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients June 2013 December 2013
NCT01878526 Completed Phase 3 Gastroesophageal Reflux Treatment in Scleroderma June 2013 January 2016
NCT01882088 Completed Phase 4 Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD April 2012 December 2016
NCT01954667 Completed Anthropometric Measures and Severity of Gastroesophageal Reflux Disease January 2012 August 2013
NCT02685150 Completed N/A Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease January 2016 June 2018
NCT02060500 Completed N/A Cardiaplication: A Novel Antireflux Operation June 2012 June 2015
NCT02072447 Completed Early Phase 1 Absolute Bioavailability of YH4808 With Accelerator Mass Spectrometry(AMS)-Based Microdose Study March 2014 April 2014
NCT02096458 Completed Phase 1 Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets February 2014 February 2014
NCT02100189 Completed N/A Esophageal Cytology With FISH in Detecting Esophageal Cancer February 2014 December 2015
NCT02135107 Completed Phase 3 A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients September 2013 June 2016
NCT02154659 Completed N/A The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms June 2014 December 7, 2015
NCT02186652 Completed Phase 1 PK Study With Pantoprazole in Obese Children and Adolescents June 4, 2014 September 13, 2015
NCT02200055 Completed N/A Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need May 2012 July 2015
NCT02637557 Completed Phase 2 A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) March 1, 2016 April 26, 2017
NCT02226484 Completed Phase 1 Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? August 2014 June 2016
NCT02579460 Completed N/A Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition November 2015 November 2017
NCT02558049 Completed N/A Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid November 2015 December 2016
NCT02486263 Completed N/A Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial December 2012 March 31, 2020
NCT02336100 Completed N/A Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis June 2011 June 2012
NCT02351960 Completed Phase 4 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease March 19, 2015 July 13, 2016
NCT02429830 Completed N/A LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy April 5, 2017 June 8, 2021
NCT02384551 Completed N/A Dietary Carbohydrate and GERD in Veterans January 25, 2016 July 1, 2022
NCT00132496 Completed Phase 2 Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole August 2005 July 2006
NCT00164840 Completed Phase 3 Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy May 2003 November 2008
NCT00165022 Completed Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population September 2003 October 2006
NCT00165841 Completed Phase 2 Maintenance Intermittent Therapy for Symptomatic GERD Patients October 2004 June 2008
NCT00174928 Completed Phase 1 A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease May 2005 August 2005
NCT06106022 Completed Phase 1 A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease November 1, 2023 April 29, 2024
NCT00200642 Completed N/A Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease December 2003 October 2007
NCT04306380 Enrolling by invitation Transoral Incisionless Fundoplication Database Repository (TIF) May 20, 2020 December 31, 2040
NCT03853772 Enrolling by invitation The Johns Hopkins Heartburn Center Registry April 27, 2019 December 2025
NCT05216133 Enrolling by invitation Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN) March 22, 2023 July 2024
NCT05937204 Not yet recruiting N/A Nursing Teaching Scheme for Patients With Gastroesophageal Reflux Disease July 1, 2023 July 1, 2024
NCT05422404 Not yet recruiting N/A Anti-Reflux Mucosal Ablation(ARMA) and Anti-Reflux Mucosectomy(ARMS) in Gastroesophageal Reflux Disease June 30, 2022 July 31, 2025
NCT06348420 Not yet recruiting N/A Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment April 10, 2024 August 13, 2027
NCT04763993 Not yet recruiting N/A Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study May 1, 2024 May 1, 2025
NCT06304142 Not yet recruiting N/A Effect of Lidocaine Block on Gastroesophageal Reflux Disease March 2024 June 2024
NCT06153901 Not yet recruiting N/A Endoloop Mediated Cardioplication to Treat Gastroesophageal Reflux Disease December 10, 2023 December 10, 2024
NCT06319521 Not yet recruiting N/A Stellate Ganglion Block on Gastroesophageal Reflux Disease March 2024 December 2024
NCT06106100 Not yet recruiting N/A Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux Disease March 2024 October 2027
NCT00574327 Recruiting Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry January 2006 January 2029
NCT01696734 Recruiting Phase 3 Domperidone in Treating Patients With Gastrointestinal Disorders October 23, 2012 October 31, 2025
NCT04036942 Recruiting N/A Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease July 15, 2019 December 1, 2022
NCT04094402 Recruiting Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD) June 4, 2019 July 2024
NCT04255693 Recruiting N/A Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence January 31, 2020 December 31, 2025
NCT05701540 Recruiting Phase 4 A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn March 24, 2023 December 31, 2024
NCT05660122 Recruiting A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab November 11, 2022 October 31, 2023
NCT05514769 Recruiting N/A Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer January 1, 2021 December 31, 2024
NCT05107219 Recruiting Phase 1 GCC Agonist Signal in the Small Intestine November 30, 2022 February 1, 2025
NCT05452980 Recruiting N/A Sleeve Gastrectomy With Reestablishment of the Acute Angle of His (SG-REACH) in Obese Patients June 1, 2022 December 30, 2025
NCT03776669 Recruiting N/A Laparoscopic Sleeve Gastrectomy With or Without Hiatal Hernia Repair in Morbidly Obese Patients January 9, 2019 December 17, 2024
NCT01580631 Suspended Narrow Band Imaging Project on Barrett's Esophagus October 2012 December 2025
NCT02227927 Temporarily not available Treatment Use of Domperidone for Gastroparesis
NCT01199679 Terminated N/A Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD) June 2011 March 2013
NCT01404832 Terminated Phase 4 The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors October 2007 May 2010
NCT00393653 Terminated N/A Prescription Methods Assessment Project (PMAP) October 2006 May 2007
NCT00536328 Terminated What is the Predictive Value of the Reflux Impact Scale October 2007 June 2008
NCT01078064 Terminated Gastric Accommodation and Gastroesophageal Reflux March 2010 November 2010
NCT01572974 Terminated Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease January 2010 December 2017
NCT00200044 Terminated N/A An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD) December 2002 June 2008
NCT01370863 Terminated Phase 2 An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients December 2, 2010 May 29, 2012
NCT02211105 Terminated Registry to Compare Two Surgical Treatments for GERD July 2014 April 2017
NCT00449813 Terminated Phase 4 The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) March 2007 November 2008
NCT02401035 Terminated Phase 4 PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects May 9, 2017 June 18, 2021
NCT01212835 Terminated N/A Effect of RING on Gastroesophageal Reflux (GERD) After RYGBP October 2010 January 2014
NCT00954070 Terminated Detection of Minimal Change Esophagitis Using Confocal Laser Endomicroscopy August 2009 April 2012
NCT00730665 Terminated Phase 2 Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD) January 2008 October 2008
NCT02762487 Terminated N/A RELIEF Europe Study November 2015 February 2017
NCT03467438 Unknown status Phase 4 Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease November 22, 2018 April 1, 2021
NCT02500264 Unknown status N/A The Effect of Non Invasive Electrical Stimulation Therapy on Gastroesophageal Reflux Disease (GERD) Symptoms - Proof of Concept Study August 2015 October 2018
NCT02255071 Unknown status N/A The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD) June 2014 December 2015
NCT01822106 Unknown status Phase 4 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) February 2013
NCT01782118 Unknown status Phase 4 LGG for Prevention of Infectious Complications During PPI Treatment in Children February 2013 July 2014
NCT02759393 Unknown status Phase 4 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis October 2015 September 2017
NCT02793479 Unknown status Radiofrequency Ablation in Patients With Barrett's Esophagus March 1, 2017 December 2021
NCT02818309 Unknown status Phase 2 Lesogaberan in Chinese Patients With Refractory Reflux Symptoms January 2015 December 2017
NCT01641887 Unknown status Decision Aid for Gastroesophageal Reflux Disease Management January 2014 December 2016
NCT01634672 Unknown status Prevalence of Gastroesophageal Reflux Disease in Peritoneal Dialysis and Hemodialysis Patients July 2010 October 2012
NCT01574339 Unknown status Phase 3 Effect of Long-Term Electrical Stimulation on LES Pressure and Esophageal Acid Exposure in Patients With GERD August 2011 July 2016
NCT02934152 Unknown status Phase 4 Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication October 2016 September 2019
NCT02984930 Unknown status N/A Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease December 2016 July 2018
NCT01504971 Unknown status Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease January 2011 December 2016
NCT03068572 Unknown status Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERD January 15, 2017 December 30, 2017
NCT01453985 Unknown status N/A Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD
NCT03223116 Unknown status N/A Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease July 1, 2015 July 1, 2018
NCT02277886 Unknown status Phase 4 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances November 2014 June 2016
NCT01249482 Unknown status Symptom Assessment for GERD Patients Receiving H. Pylori Eradication September 2010 August 2012
NCT01128608 Unknown status N/A The Effect of High PCO2 Solution on Esophageal Acid Sensation September 2009 November 2010
NCT01128582 Unknown status Phase 3 Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. March 2009 December 2011
NCT01107938 Unknown status Phase 2 Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients May 2010
NCT04129008 Unknown status Phase 4 GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy October 17, 2019 December 31, 2020
NCT01089959 Unknown status Phase 2/Phase 3 Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD March 2010 March 2012
NCT04696783 Unknown status Phase 3 The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers July 2021 November 2021
NCT00564590 Unknown status Phase 1/Phase 2 SThe Effects of Melatonin on GERD Symptoms October 2008 January 2011
NCT00539786 Unknown status N/A The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD March 2006
NCT00498082 Unknown status Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease September 2007 September 2008
NCT00480285 Unknown status Phase 3 A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients November 2006 November 2011
NCT02457104 Unknown status The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43 June 2015 December 2021
NCT00591877 Withdrawn N/A A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD Patients December 2012 January 2015
NCT00915616 Withdrawn Phase 3 The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
NCT00928161 Withdrawn N/A Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy November 2012
NCT04311541 Withdrawn A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation March 15, 2020 January 31, 2022
NCT04052581 Withdrawn Prospective Collection of Outcome Data Post POEM-TIF Procedure July 2023 July 26, 2023
NCT01391715 Withdrawn Phase 3 Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD August 2011 December 2012
NCT01471925 Withdrawn Phase 3 Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC
NCT01479231 Withdrawn Phase 1/Phase 2 Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis March 2012 March 2012
NCT06215742 Withdrawn N/A Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease January 30, 2024 May 15, 2024
NCT01710462 Withdrawn Phase 3 Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease August 2013
NCT00584675 Withdrawn N/A Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers February 2007 February 2008
NCT02039869 Withdrawn N/A Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)
Disase is a (Disease Ontology)
DOID:77
Cross Reference ID (Disease Ontology)
ICD10CM:K21.9
Cross Reference ID (Disease Ontology)
ICD9CM:530.81
Cross Reference ID (Disease Ontology)
MESH:D005764
Cross Reference ID (Disease Ontology)
MIM:109350
Cross Reference ID (Disease Ontology)
NCI:C26781
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:235595009
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0017168
Exact Synonym (Disease Ontology)
Acid reflux
Exact Synonym (Disease Ontology)
Gastresophageal reflux
Exact Synonym (Disease Ontology)
Gastro-esophageal reflux
Exact Synonym (Disease Ontology)
Gastroesophageal reflux
Exact Synonym (Disease Ontology)
GERD
Exact Synonym (Disease Ontology)
GERD - Gastro-esophageal reflux disease